Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.2586dup | p.Glu863X | Heterozygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
GAG | Glu | ins1a | Fs. | Stop at 863 | Fr. |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
Hybrid motif #02 |
At the mRNA level | On restriction map |
Duplication flanked by direct repeats | New restriction site(s): none Lost restriction site(s): none |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
BEL01GHE F0061 I2034 | Proband | Male | familial | 39 years old | BELGIUM |
Phenotypic group | Disease |
NA | Classical MFS |
Symptom |
C-Asc. aortic dilatation |
CF-Dolichocephaly |
CF-Down-slanting palpebral fissures |
CF-Malar hypoplasia |
CF-Retrognathia |
CNS-Lumbosacral dural ectasia |
L-Spontaneous pneumothorax |
S-Arachnodactyly (M) |
S-Arm span/height >1.05 (M) |
S-Chest deformity (unspecified) |
S-Reduced US/LS ratio <0.87 (M) |
S-Scoliosis > 20° (M)(1) |
SI-Significant striae atrophicae (m)(1) |
Reference ID | PubMed ID | Reference |
89 | 11700157 | Loeys B, Nuytinck L, Delvaux I, De Bie S, De Paepe A. "Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome". Arch Intern Med. 2001 Nov 12;161(20):2447-54. |